Contract drug firm Aptuit to invest $ 100 mn
Global contract drug development firm Aptuit Inc and Hyderabad-based Laurus Labs Limited on Monday announced the formation of a contract drug development company, Aptuit Laurus, in India.
By PTI |
BANGALORE: Global contract drug development firm Aptuit Inc and Hyderabad-based Laurus Labs Limited on Monday announced the formation of a contract drug development company, Aptuit Laurus, in India.
"The company will combine Aptuit's global offerings in drug development with Laurus' R and D and manufacturing expertise and newly built state-of-the-art facilities to provide established and emerging pharmaceutical companies with integrated services, technologies and manufacturing capabilities that span the entire drug development lifecycle," an Aptuit statement said.
Aptuit Inc plans to invest over USD 100 million over the next four years to build upon Aptuit Laurus' development, manufacturing and informatics capabilities, it said.
The new entity will use the trade name Aptuit Laurus,and will be based in Hyderabad with additional facilities in Vishakhapatnam and Bangalore.
The company will initially provide services to clients in early-stage drug discovery, medicinal chemistry, lead optimisation, process development, scale-up and process optimisation, safety and hazard assessment, formulation development and analytical chemistry.
Aptuit Laurus will comprise Laurus' newly-established 160,000 square foot research and development facility in Hyderabad, which already employs over 200 scientific personnel, Laurus large-scale manufacturing plant, which is currently under construction on over 34 acres of land in pharma city, Vishakhapatnam and Aptuit's existing Informatics Development and Support group of 100 employees here.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
